The Dichotomy of Alzheimer's Disease Pathology: Amyloid-β and Tau

Journal of Alzheimer's Disease : JAD
J Wesson Ashford

Abstract

In this issue, an article by Tiepolt et al. shows that PET scanning using [11C]PiB can demonstrate both cerebral blood flow (CBF) changes and amyloid-β (Aβ) deposition in patients with mild cognitive dysfunction or mild dementia of Alzheimer's disease (AD). The CBF changes can be determined because the early scan counts (1-9 minutes) reflect the flow of the radiotracer in the blood passing through the brain, while the Aβ levels are measured by later scan counts (40-70 minutes) after the radiotracer has been cleared from regions to which the radiotracer did not bind. Thus, two different diagnostic measures are obtained with a single injection. Unexpectedly, the mild patients with Aβ positivity had scan data with only a weak relationship to memory, while the relationships to executive function and language function were relatively strong. This divergence of findings from studies of severely impaired patients highlights the importance of determining how AD pathology affects the brain. A possibility suggested in this commentary is that Aβ deposits occur early in AD and specifically in critical areas of the neocortex affected only later by the neurofibrillary pathology indicating a different role of the amyloid-β protein precursor (...Continue Reading

References

Dec 31, 1976·Archiv für Psychiatrie und Nervenkrankheiten·A Brun, L Gustafson
Jan 1, 1992·International Psychogeriatrics·J W AshfordS Vicari
Oct 1, 1991·Trends in Pharmacological Sciences·J Hardy, D Allsop
Jan 1, 1990·The American Journal of Psychiatry·L Jarvik
Aug 8, 1985·The New England Journal of Medicine·T P BeresfordR C Hall
Jul 1, 1968·The British Journal of Psychiatry : the Journal of Mental Science·G BlessedM Roth
Jan 1, 1996·Acta Neurologica Scandinavica. Supplementum·H Braak, E Braak
Jul 1, 1997·Neurobiology of Aging·J W GeddesW R Markesbery
Oct 24, 1998·Journal of Neuropathology and Experimental Neurology·J W AshfordJ W Geddes
Sep 13, 2002·Journal of Alzheimer's Disease : JAD·J Wesson Ashford
Dec 4, 2003·Neurobiology of Aging·Paul D Coleman, Pamela J Yao
Dec 4, 2003·Journal of Alzheimer's Disease : JAD·Marta S MendiondoFrederick A Schmitt
Mar 3, 2004·Annals of Neurology·William E KlunkBengt Långström
Jun 3, 2004·Neurobiology of Aging·Jacob RaberJ Wesson Ashford
Jun 8, 2004·Journal of Molecular Neuroscience : MN·J Wesson Ashford
Dec 2, 2008·Brain : a Journal of Neurology·E C MorminoUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Feb 27, 2010·Annals of Neurology·John C MorrisMark A Mintun
Apr 26, 2011·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Clifford R JackCreighton H Phelps
Oct 6, 2011·Journal of Alzheimer's Disease : JAD·J Wesson AshfordGeorge Perry
Apr 11, 2012·Journal of Neuropathology and Experimental Neurology·Peter T NelsonThomas G Beach
May 1, 2012·Journal of Alzheimer's Disease : JAD·Michel BenoitPhilippe Robert
Oct 23, 2012·Archives of Medical Research·Rudy J Castellani, George Perry
Apr 5, 2013·JAMA Neurology·Karen M RodrigueDenise C Park
May 28, 2013·Neuroscience and Biobehavioral Reviews·Ludwig TrilloAhmad Salehi
Oct 1, 2013·Alzheimer Disease and Associated Disorders·Arunabha ChakrabartiDebashis Mukhopadhyay
Jan 15, 2014·Biochemical Pharmacology·Stephen W ScheffPeter T Nelson
Jan 23, 2014·Biochemical Pharmacology·Rudy J Castellani, George Perry
Mar 29, 2014·Journal of Neurochemistry·Roberto Cappai
Jun 15, 2014·Neurology·Davis C RymanUNKNOWN Dominantly Inherited Alzheimer Network
May 27, 2015·Nature Neuroscience·Erik S Musiek, David M Holtzman
Oct 22, 2015·Current Alzheimer Research·Ahmad SalehiElliott J Mufson
Mar 31, 2016·EMBO Molecular Medicine·Dennis J Selkoe, John Hardy
Apr 1, 2016·Journal of Alzheimer's Disease : JAD·Katherine J BangenUNKNOWN Alzheimer’s Disease Neuroimaging Initiative

❮ Previous
Next ❯

Citations

Jan 17, 2020·Aging Medicine·Xianbo Zhou, J Wesson Ashford
Jul 28, 2019·Medicinal Research Reviews·Nour M Moussa-PachaTaleb H Al-Tel
Jan 27, 2022·Journal of Molecular Neuroscience : MN·Sha LiuDeqin Geng

❮ Previous
Next ❯

Methods Mentioned

BETA
amputation

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Related Papers

European Journal of Nuclear Medicine and Molecular Imaging
Ryuichi HaradaYukitsuka Kudo
PloS One
Rahul S DesikanAlzheimer's Disease Neuroimaging Initiative
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Lars FringsPhilipp T Meyer
© 2022 Meta ULC. All rights reserved